Search

Your search keyword '"Campagna, Roberta"' showing total 10 results
Start Over Author "Campagna, Roberta" Publication Year Range Last 3 years
10 results on '"Campagna, Roberta"'

1. Sequence analysis of respiratory syncytial virus cases reveals a novel subgroup -B strain circulating in north-central Italy after pandemic restrictions

Author

Pierangeli, Alessandra, Midulla, Fabio, Piralla, Antonio, Ferrari, Guglielmo, Nenna, Raffaella, Pitrolo, Antonino Maria Guglielmo, Licari, Amelia, Marseglia, Gian Luigi, Abruzzese, Dario, Pellegrinelli, Laura, Galli, Cristina, Binda, Sandro, Cereda, Danilo, Fracella, Matteo, Oliveto, Giuseppe, Campagna, Roberta, Petrarca, Laura, Pariani, Elena, Antonelli, Guido, and Baldanti, Fausto

Published
2024
Full Text
View/download PDF

5. SARS-CoV-2 infection predicts larger infarct volume in patients with acute ischemic stroke

Author

De Michele, Manuela, primary, Lorenzano, Svetlana, additional, Piscopo, Paola, additional, Rivabene, Roberto, additional, Crestini, Alessio, additional, Chistolini, Antonio, additional, Stefanini, Lucia, additional, Pulcinelli, Fabio M., additional, Berto, Irene, additional, Campagna, Roberta, additional, Amisano, Paolo, additional, Iacobucci, Marta, additional, Cirelli, Carlo, additional, Falcou, Anne, additional, Nicolini, Ettore, additional, Schiavo, Oscar G., additional, and Toni, Danilo, additional

Published
2023
Full Text
View/download PDF

6. Longitudinal Virological and Immunological Profile in a Case of Human Monkeypox Infection

Author

Zingaropoli, Maria Antonella, primary, Parente, Alberico, additional, Kertusha, Blerta, additional, Campagna, Roberta, additional, Tieghi, Tiziana, additional, Garattini, Silvia, additional, Marocco, Raffaella, additional, Carraro, Anna, additional, Tortellini, Eeva, additional, Guardiani, Mariasilvia, additional, Dominelli, Federica, additional, Turriziani, Ombretta, additional, Ciardi, Maria Rosa, additional, Mastroianni, Claudio Maria, additional, Del Borgo, Cosmo, additional, and Lichtner, Miriam, additional

Published
2022
Full Text
View/download PDF

7. Assessment of Anxiety, Depression, Work-Related Stress, and Burnout in Health Care Workers (HCWs) Affected by COVID-19: Results of a Case–Control Study in Italy

Author

La Torre, Giuseppe, primary, Barletta, Vanessa India, additional, Marte, Mattia, additional, Paludetti, Francesca, additional, Faticoni, Augusto, additional, Barone, Lavinia Camilla, additional, Rocchi, Ilaria, additional, Picchioni, Filippo, additional, Previte, Carlo Maria, additional, Serruto, Pasquale, additional, Deriu, Gloria, additional, Ajassa, Camilla, additional, Campagna, Roberta, additional, Antonelli, Guido, additional, and Matroianni, Claudio Maria, additional

Published
2022
Full Text
View/download PDF

8. Phylogeography and genomic epidemiology of SARS-CoV-2 in Italy and Europe with newly characterized Italian genomes between February-June 2020

Author

Lai, Alessia, Bergna, Annalisa, Toppo, Stefano, Morganti, Marina, Menzo, Stefano, Ghisetti, Valeria, Bruzzone, Bianca, Codeluppi, Mauro, Fiore, Vito, Rullo, Emmanuele Venanzi, Antonelli, Guido, Sarmati, Loredana, Brindicci, Gaetano, Callegaro, Annapaola, Sagnelli, Caterina, Francisci, Daniela, Vicenti, Ilaria, Miola, Arianna, Tonon, Giovanni, Cirillo, Daniela, Menozzi, Ilaria, Caucci, Sara, Cerutti, Francesco, Orsi, Andrea, Schiavo, Roberta, Babudieri, Sergio, Nunnari, Giuseppe, Mastroianni, Claudio M., Andreoni, Massimo, Monno, Laura, Guarneri, Davide, Coppola, Nicola, Crisanti, Andrea, Galli, Massimo, Zehender, Gianguglielmo, Balotta, Claudia, Ventura, Carla della, Schiuma, Marco, Lavezzo, Enrico, Fontana, Paolo, Bianco, Luca, Bertolotti, Luigi, Manuto, Laura, Grazioli, Marco, Bianca, Federico, Del Vecchio, Claudia, Franchin, Elisa, Onelia, Francesco, Spitaleri, Andrea, Saluzzo, Francesca, Lorenzin, Giovanni, Pongolini, Stefano, Scaltriti, Erika, Soliani, Laura, Bagnarelli, Patrizia, Turchi, Chiara, Onofri, Valerio, Melchionda, Filomena, Tagliabracci, Adriano, Burdino, Elisa, Milia, Maria Grazia, Caligiuri, Patrizia, De Pace, Vanessa, Ricucci, Valentina, Domnich, Alexander, Boccotti, Simona, Cristina, Leoni Maria, Cascio, Giuliana Lo, Rubino, Salvatore, Lai, Vincenzo, Rocca, Giulia, Govoni, Rosalba, Mancuso, Giuseppe, Campagna, Roberta, Mazzuti, Laura, Oliveto, Giuseppe, Turriziani, Ombretta, Campogiani, Laura, Compagno, Mirko, Coppola, Luigi, Crea, Angela Maria Antonia, De Simone, Giuseppe, Di Lorenzo, Andrea, Ferrari, Ludovica, Iannetta, Marco, Malagnino, Vincenzo, Mulas, Tiziana, Rossi, Benedetta, Spalliera, Ilaria, Tedde, Simona, Teti, Elisabetta, Vitale, Pietro, Zordan, Marta, Milano, Eugenio, Lagioia, Antonella, Gallitelli, Rosa, Starace, Mario, Minichini, Carmine, Di Fraia, Alessia, Schioppa, Maddalena, Greco, Rita, Gidari, Anna, Zazzi, Maurizio, Dragoni, Filippo, Puma, Laura Li, Ronchiadin, Silvia, Ruggerone, Luigi, Russignaga, Dario, Lai, Alessia, Bergna, Annalisa, Toppo, Stefano, Morganti, Marina, Menzo, Stefano, Ghisetti, Valeria, Bruzzone, Bianca, Codeluppi, Mauro, Fiore, Vito, Rullo, Emmanuele Venanzi, Antonelli, Guido, Sarmati, Loredana, Brindicci, Gaetano, Callegaro, Annapaola, Sagnelli, Caterina, Francisci, Daniela, Vicenti, Ilaria, Miola, Arianna, Tonon, Giovanni, Cirillo, Daniela, Menozzi, Ilaria, Caucci, Sara, Cerutti, Francesco, Orsi, Andrea, Schiavo, Roberta, Babudieri, Sergio, Nunnari, Giuseppe, Mastroianni, Claudio M, Andreoni, Massimo, Monno, Laura, Guarneri, Davide, Coppola, Nicola, Crisanti, Andrea, Galli, Massimo, and Zehender, Gianguglielmo

Subjects
Europe, Phylogeography, Genome, Italy, SARS-CoV-2, Communicable Disease Control, Humans, COVID-19, Genome, Viral, Viral, Settore MED/17, Human
Abstract

The aims of this study were to characterize new SARS-CoV-2 genomes sampled all over Italy and to reconstruct the origin and the evolutionary dynamics in Italy and Europe between February and June 2020. The cluster analysis showed only small clusters including < 80 Italian isolates, while most of the Italian strains were intermixed in the whole tree. Pure Italian clusters were observed mainly after the lockdown and distancing measures were adopted. Lineage B and B.1 spread between late January and early February 2020, from China to Veneto and Lombardy, respectively. Lineage B.1.1 (20B) most probably evolved within Italy and spread from central to south Italian regions, and to European countries. The lineage B.1.1.1 (20D) developed most probably in other European countries entering Italy only in the second half of March and remained localized in Piedmont until June 2020. In conclusion, within the limitations of phylogeographical reconstruction, the estimated ancestral scenario suggests an important role of China and Italy in the widespread diffusion of the D614G variant in Europe in the early phase of the pandemic and more dispersed exchanges involving several European countries from the second half of March 2020.

Published
2022

9. Pfizer-BioNTech COVID-19 Vaccine in Gynecologic Oncology Patients: A Prospective Cohort Study

Author

Palaia, Innocenza, primary, Caruso, Giuseppe, additional, Di Donato, Violante, additional, Vestri, Annarita, additional, Napoli, Anna, additional, Perniola, Giorgia, additional, Casinelli, Matteo, additional, Alunni Fegatelli, Danilo, additional, Campagna, Roberta, additional, Tomao, Federica, additional, D’Aniello, Debora, additional, Antonelli, Guido, additional, and Muzii, Ludovico, additional

Published
2021
Full Text
View/download PDF

10. Pfizer-BioNTech COVID-19 Vaccine in Gynecologic Oncology Patients: A Prospective Cohort Study.

Author

Palaia, Innocenza, Caruso, Giuseppe, Di Donato, Violante, Vestri, Annarita, Napoli, Anna, Perniola, Giorgia, Casinelli, Matteo, Alunni Fegatelli, Danilo, Campagna, Roberta, Tomao, Federica, D'Aniello, Debora, Antonelli, Guido, and Muzii, Ludovico

Subjects
COVID-19 vaccines, GYNECOLOGIC oncology, CANCER vaccines, CANCER patients, COHORT analysis
Abstract

Objective: To evaluate the safety and immunogenicity of the Pfizer-BioNTech COVID-19 vaccine in gynecologic oncology patients under chemotherapy. Methods: A prospective cohort study including gynecologic oncology women who were under chemotherapy or had completed it within 6 months at the time of the study. All patients received a two-dose schedule of the Pfizer-BioNTech COVID-19 vaccine. Results were compared with a control group of healthy women vaccinated in the same period. Results: Overall, 44 oncologic patients with a mean age of 61.3 ± 10.7 years were enrolled: 28 (63.6%) had ovarian cancer, 9 (20.4%) endometrial, and 7 (16%) cervical. The IgG antibody titer after 1 month from vaccination was low in 9 (20.5%) patients, moderate in 21 (47.7%), and high in 14 (31.8%). The 3-month titer was null in 2 (4.5%) patients, low in 26 (59.1%), moderate in 13 (29.5%), and high in 3 (6.8%). Patients ≥ 50 years reported lower 1-month (p = 0.018) and 3-month (p = 0.004) titers compared with <50 years. Patients with BMI < 30 kg/m2 had a higher 1-month titer compared with BMI ≥ 30 kg/m2 (p = 0.016). Compared with healthy women (n = 44), oncologic patients showed a lower 3-month titer (p < 0.001). None of the patients experienced serious adverse effects. Conclusions: The COVID-19 vaccine was safe and immunogenic in gynecologic oncology patients under chemotherapy. Serological monitoring and further vaccine shots should be considered to boost protection. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results